Physician

Megan Elizabeth Janson, M.D.

According to 2025 Medicare claims, Megan Janson, M.D. (NPI: 1366738478) practices family practice in the Miami-Miami Beach-Kendall, FL market, with the plurality of this provider's patient population coming from Miami-Dade, FL. This provider's primary affiliated billing organization is PROHEALTH MEDICAL GROUP INC. (NPI: 1164086815; TIN: 834078120) and primary practice location at 33172-4501. Janson is affiliated with the Main Street Rural Health Sycamore ACO LLC (ACO ID: A5403) and Main Street Rural Health Dogwood ACO LLC (ACO ID: A5421), participating under the MSSP model.

Janson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 24 traditional Medicare patients, billed 154 HCPCS/CPT codes, and received $5,792 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 909 prescription claims across 134 beneficiaries totaling $62,329 in drug costs, led by Ozempic (Semaglutide). 2023 DME data shows 24 claims. Open Payments data shows 6 records totaling $120. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $612 to $5,792. Similarly, Part D prescription costs have fallen sharply in recent years, from $178,550 to $62,329. For DME billing, reported payments fell sharply in recent years, from $711 to $2,002.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	14	17	$612
2017	495	1,452	$111,397
2018	541	1,366	$99,273
2019	425	857	$62,807
2020	408	1,018	$83,868
2021	49	86	$4,636
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	24	154	$5,792

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	362	3,849	$178,550
2016	357	4,617	$237,531
2017	711	14,176	$558,653
2018	912	15,822	$932,971
2019	834	17,702	$1,108,685
2020	739	14,733	$867,248
2021	552	6,470	$448,749
2022	232	2,690	$190,774
2023	230	2,468	$176,807
2024	134	909	$62,329

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	18	$345
2017	N/R	182	$5,158
2018	201	754	$57,442
2019	276	1,167	$68,968
2020	204	829	$62,498
2021	N/R	465	$37,892
2022	N/R	117	$11,328
2023	N/R	24	$1,671
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	16	33	$92
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	11	18	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	20	644	$21,329
Gabapentin	Gabapentin	37	1,404	$637
Atorvastatin Calcium	Atorvastatin Calcium	64	3,170	$417
Levetiracetam	Levetiracetam	14	420	$411
Amlodipine Besylate	Amlodipine Besylate	44	2,055	$284

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$120	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Megan Elizabeth Janson, M.D.?

Tedicare shows public-source Medicare data for Megan Elizabeth Janson, M.D. (NPI 1366738478), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Megan Elizabeth Janson, M.D. have ACO affiliation data?

Megan Elizabeth Janson, M.D. is shown with ACO affiliation data for Main Street Rural Health Sycamore ACO LLC (MSSP, ACO ID A5403) and Main Street Rural Health Dogwood ACO LLC (MSSP, ACO ID A5421).

What billing organization is linked to Megan Elizabeth Janson, M.D.?

Megan Elizabeth Janson, M.D. is linked to PROHEALTH MEDICAL GROUP INC. (billing NPI 1164086815) in the available physician profile data.

Does Megan Elizabeth Janson, M.D. have Open Payments data?

Megan Elizabeth Janson, M.D. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.